DK0906912T3 - Indanolforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger som indeholder disse - Google Patents

Indanolforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger som indeholder disse

Info

Publication number
DK0906912T3
DK0906912T3 DK98402415T DK98402415T DK0906912T3 DK 0906912 T3 DK0906912 T3 DK 0906912T3 DK 98402415 T DK98402415 T DK 98402415T DK 98402415 T DK98402415 T DK 98402415T DK 0906912 T3 DK0906912 T3 DK 0906912T3
Authority
DK
Denmark
Prior art keywords
alkyl
alkoxy
atoms
processes
preparation
Prior art date
Application number
DK98402415T
Other languages
Danish (da)
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Adrian Newman-Tancredi
Anne Dekeyne
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0906912T3 publication Critical patent/DK0906912T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK98402415T 1997-10-03 1998-10-01 Indanolforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger som indeholder disse DK0906912T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9712336A FR2769312B1 (fr) 1997-10-03 1997-10-03 Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0906912T3 true DK0906912T3 (da) 2003-04-22

Family

ID=9511782

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98402415T DK0906912T3 (da) 1997-10-03 1998-10-01 Indanolforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger som indeholder disse

Country Status (19)

Country Link
US (2) US5958927A (zh)
EP (1) EP0906912B1 (zh)
JP (1) JP3884177B2 (zh)
CN (1) CN1122666C (zh)
AT (1) ATE230739T1 (zh)
AU (1) AU736710B2 (zh)
BR (1) BR9804485A (zh)
CA (1) CA2249756C (zh)
DE (1) DE69810560T2 (zh)
DK (1) DK0906912T3 (zh)
ES (1) ES2190574T3 (zh)
FR (1) FR2769312B1 (zh)
HK (1) HK1019736A1 (zh)
HU (1) HUP9802194A1 (zh)
NO (1) NO316693B1 (zh)
NZ (1) NZ332142A (zh)
PL (1) PL191091B1 (zh)
PT (1) PT906912E (zh)
ZA (1) ZA989011B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769312B1 (fr) * 1997-10-03 1999-12-03 Adir Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0982304B1 (en) * 1998-06-30 2002-10-02 Eli Lilly And Company Piperidine derivatives having effects on serotonin related systems
US6197798B1 (en) 1998-07-21 2001-03-06 Novartis Ag Amino-benzocycloalkane derivatives
PT1259484E (pt) * 2000-01-18 2005-09-30 Novartis Ag Carboxamidas uteis como inibidores de proteina de transferencia de triglicerido microsomal e de secrecao de apolipoproteina b
US20020077278A1 (en) * 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
JP5080716B2 (ja) 2001-07-20 2012-11-21 サイコジェニックス・インコーポレーテッド 注意欠陥・多動性障害の治療
DE10142662B4 (de) 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
FR2883876B1 (fr) * 2005-03-30 2007-05-04 Servier Lab Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3571436D1 (en) * 1984-12-21 1989-08-17 Duphar Int Res New pharmaceutical compositions having anti-psychotic properties
WO1987002035A1 (en) * 1985-10-04 1987-04-09 Maggioni-Winthrop S.P.A. Fused cycloaliphatic aminoalcohols
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2769312B1 (fr) * 1997-10-03 1999-12-03 Adir Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO984620L (no) 1999-04-06
NO984620D0 (no) 1998-10-02
EP0906912A1 (fr) 1999-04-07
NO316693B1 (no) 2004-03-26
ES2190574T3 (es) 2003-08-01
HU9802194D0 (en) 1998-11-30
CA2249756A1 (fr) 1999-04-03
HK1019736A1 (en) 2000-02-25
FR2769312B1 (fr) 1999-12-03
BR9804485A (pt) 2000-04-11
AU736710B2 (en) 2001-08-02
US6060487A (en) 2000-05-09
US5958927A (en) 1999-09-28
AU8787598A (en) 1999-04-22
EP0906912B1 (fr) 2003-01-08
PT906912E (pt) 2003-04-30
CN1218051A (zh) 1999-06-02
NZ332142A (en) 2000-05-26
JPH11158179A (ja) 1999-06-15
DE69810560D1 (de) 2003-02-13
HUP9802194A1 (hu) 1999-12-28
DE69810560T2 (de) 2003-11-27
CN1122666C (zh) 2003-10-01
CA2249756C (fr) 2003-12-02
PL328989A1 (en) 1999-04-12
JP3884177B2 (ja) 2007-02-21
ZA989011B (en) 1999-04-12
FR2769312A1 (fr) 1999-04-09
PL191091B1 (pl) 2006-03-31
ATE230739T1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
NZ331613A (en) Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives
DK0906912T3 (da) Indanolforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger som indeholder disse
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
DE69802249D1 (de) Neue N-Aryl-2-hydroxy-alkylamide
FI933719A0 (fi) 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol
IL103595A0 (en) 2-heterocyclicethylamine derivatives,their preparation and pharmaceutical compositions containing them
DK0783495T3 (da) Quinoxalinderivater, der er egnede i terapi
DK544689D0 (da) Terapeutisk aktive forbindelser
DE60005525D1 (de) 2-aminotetraline zur behandlung von glaukom
ATE199897T1 (de) Aminierte 6,7,8,9-tetrahydro- cyclopenta(a)naphthalen- und 2,3-dihydro- cyclopenta(e)inden-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
FI831068A0 (fi) Foerfarande foer framstaellning av enantiomerer av substituerade fenylazacykloalkaner med farmaceutaktivitet
FR2695643B1 (fr) Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant.
FR2705344B1 (fr) Dérivés de 2-aminopyrazine-5-carboxamide, leur préparation et leur application en thérapeutique.
IE890161L (en) 2-Amino Acetamide Derivatives
MX9707839A (es) Derivado de acetamida, procesos para la preparacion del mismo, y composiciones farmaceuticas que contienen el mismo.
FI882421A0 (fi) 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h -benz(e)indol, deras framstaellning och anvoendning som laekemedel.